Antibodies against programmed cell death 1 (PD1) and PD1 ligand (PD‐L1) have shown great promises in fighting against cancers and thus attracted much attention during recent years61, 63, 64 (Figure 2). The gene discussed is PDCD1; the disease is cancer.